Ramunas Janavicius

Summary

Affiliation: Vilnius University
Country: Lithuania

Publications

  1. ncbi Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  2. ncbi Microsatellite instability detection by high-resolution melting analysis
    Ramunas Janavicius
    Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Clin Chem 56:1750-7. 2010
  3. ncbi Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation
    Ramunas Janavicius
    Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Breast J 17:409-15. 2011

Collaborators

  • Arturas Jakubauskas
  • Griselda Martrat
  • Marie Stenmark-Askmalm
  • Georgia Chenevix-Trench
  • Siranoush Manoukian
  • Barbara Pasini
  • Esther M John
  • Ute Hamann
  • Amanda Spurdle
  • Juan Bueren
  • Fergus J Couch
  • Eitan Friedman
  • Julian Ceron
  • Isabelle Mortemousque
  • Joan Brunet
  • Sylvie Mazoyer
  • Montserrat Porta-de-la-Riva
  • Maria J Ramirez
  • Debra Frost
  • Carol Chu
  • Xianshu Wang
  • Ake Borg
  • Bella Kaufman
  • Sheila Seal
  • Christi J Asperen
  • Theo A van Os
  • Anthony Renwick
  • Paolo Radice
  • Helena Aguilar
  • Sandra Fert Ferrer
  • Hanne E J Meijers-Heijboer
  • Carole Brewer
  • Detlev Schindler
  • Kaoru Tominaga
  • Monica Barile
  • Shirley Hodgson
  • Patrick J Morrison
  • Kai Ren Ong
  • Mary Porteous
  • Trinidad Caldes
  • Oskar Thor Johannsson
  • Marie Agnès Collonge-Rame
  • Matti A Rookus
  • Daniela Zaffaroni
  • Senno Verhoef
  • Yael Laitman
  • Laurent Castera
  • Miguel Angel Pujana
  • Alexander Miron
  • Olga M Sinilnikova
  • Melissa Southey
  • Roni Milgrom
  • Heli Nevanlinna
  • Alessandra Viel
  • Madeleine A Tilanus-Linthorst
  • Rosemarie Davidson
  • Javier Benitez
  • Philippe Vennin
  • Olivia M Pereira-Smith
  • Timothy R Rebbeck
  • David E Goldgar
  • Margaret Cook
  • Jackie Cook
  • D Gareth Evans
  • Louise Izatt
  • Gisela Barbany-Bustinza
  • Margreet G E M Ausems
  • Laura Ottini
  • Reinhard Depping
  • Marinus J Blok
  • Katherine L Nathanson
  • Mary B Daly
  • Victor Moreno
  • Gaia Roversi
  • Conxi Lazaro
  • Rosalind Eeles
  • Tuomas Heikkinen
  • Christopher M Maxwell
  • Evgeny N Imyanitov
  • Lesley McGuffog
  • Fiona Lalloo
  • Antoine de Pauw
  • Maria Castella
  • Katja Harbst
  • Massimo Bogliolo
  • Johanna Rantala
  • Nuria Bonifaci
  • Daniel Cuadras
  • Susan M Domchek
  • Kornelia Neveling

Detail Information

Publications3

  1. ncbi Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  2. ncbi Microsatellite instability detection by high-resolution melting analysis
    Ramunas Janavicius
    Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Clin Chem 56:1750-7. 2010
    ..A new high-resolution melting (HRM) analysis method enables rapid identification of heteroduplexes in amplicons by their lower thermal stability, a technique that overcomes the main shortcomings of capillary electrophoresis and DHPLC...
  3. ncbi Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation
    Ramunas Janavicius
    Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Breast J 17:409-15. 2011
    ..817C>T (p.R273C) mutation carrier and discuss the importance of peri-diagnostic oncogenetic TP53 testing in early breast cancer cases. Histopathology and genetic modifiers (MDM2 SNP309G; TP53 R72P, PIN3) data are also addressed...